跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PMP-1
首页
药物
PMP-1
PMP-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SET OF SEQUENCES FOR TARGETING EXPRESSION AND CONTROL OF THE POST-TRANSLATIONAL MODIFICATION OF A RECOMBINANT POLYPEPTIDE
US 2011195452 A1
申请人: CENTRE NAT RECH SCIENT
优先权: 2006
CN
US
2 件公开
Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
US 6900342 B2
申请人: DABUR INDIA LTD
优先权: 2002
US
2 件公开
种席夫碱铂配合物及其制备方法和应用
CN 104910212 B
申请人: 山西大学
优先权: 2015
CN
Controllable medication conveying system based on Multi-arm star-shaped copolymer
CN 106366321 A
申请人: UNIV JIANGNAN
优先权: 2016
CN
Combined hair dye and preparation method
CN 107041858 A
申请人: WENDA INT BIOTECHNOLOGY SHENZHEN CO LTD
优先权: 2017
CN
Liquid compositions comprising peptide aldehydes
CN 116057066 A
申请人: BASF SE
优先权: 2020
CN
Serine protease capable of selectively degrading mucoprotein and application of serine protease
CN 115786311 A
申请人: SUN ZHENGLONG
优先权: 2022
CN
药物
反馈